二甲双胍改善2型糖尿病胰岛素抵抗的临床研究(2)
第1页 |
参见附件。
参考文献
[1]陈灏珠,廖履坦,杨秉辉,等.实用内科学[M].第12版.北京:人民卫生出版社,2005:1019.
[2] UK Prospective Diabetes Study (UKPDS) Group.Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS33)[J].Lancet,1998,352(9131):837-853.
[3]张梅,邓尚平.2型糖尿病早期胰岛素应用的几个问题[J].中华糖尿病杂志,2005,13(6):471-472.
[4] Wang C C,Goalstone M L,Draznin B.Molecular mechanisms of insulin resistance that impact cardiovascular biology[J].Diabetes,2004,53(11):2735.
[5]孙志香,吴静,雷闽湘.纯性肥胖患者血清瘦素的变化及其与胰岛素抵抗的关系[J].中国现代医学杂志,2004,14(5):126.
[6]李光伟,潘孝仁,Lillioja S,等.检测人群胰岛素敏感性的一项新指数[J].中华内科杂志,1993,32(4):656.
[7] Pravenec M,Kazdoval,Landa V,et al.Transgenic and recombinant resistin impair skeletal muscle glucose metabolism in the spontaneously ypertensive rat[J].J Biol Chem,2003,278(46):45209.
[8] Shojima N,Sakoda H,Ogihara T,et al.Humoral regulation of resistin expression in 3T3-L1 and mouse adipose cells[J].Diabetes,2002,51(6):1737.
(收稿日期:2013-11-15) (编辑:陈春梅)
您现在查看是摘要介绍页,详见PDF附件。